
|Articles|February 1, 2004
Inspirational biologics
Waikoloa, Hawaii - Psoriatic patients responding to efalizumab (Raptiva, Genentech Inc. and Xoma Ltd.) biologic medication are happy with the results after an extended period of continuous treatment.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
A Patient–Physician Lens on the Real Burden of CHE
2
When Hives Do Not Quit: A Practical Update on Chronic Spontaneous Urticaria
3
Celldex Advances Barzolvolimab into Phase 3 for Cold Urticaria and Symptomatic Dermographism
4
New Perspectives in Chronic Hand Eczema Care
5



















